STACEY LITTLE: Open Payments
NPI 1831396415 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 34 payments from 5 companies in 2025. Trend: 2023 $354 · 2024 $75 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 22 | $304 |
| Collegium Pharmaceutical, Inc. | 5 | $105 |
| SCILEX PHARMACEUTICALS INC. | 5 | $102 |
| PFIZER INC. | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: PROLATE, Belbuca, ZTLido, ELYXYB - CELECOXIB, DUAVEE, RELISTOR.
Industry payments across CA — which companies pay providers there.
